ATRA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $9.48

Capitalizzazione di Mercato (MRQ) $90M

P/E (TTM) -5.5

EPS (TTM) $-1.73

Ricavi (TTM) $6M

ROE (TTM) 46.3%

Intervallo 52 sett. $4–$19

ATRA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Split azionari 1

Data ex-dividendo	Split	Tipo
20 Giugno 2024	1-for-25	Inverso

Informazioni su Atara Biotherapeutics, Inc. - Common Stock Panoramica della società da Wikipedia

05 · wikidata

Wikidata ↗

settoreHealthcare industriaBiotechnology dipendenti10 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$121M

2022-12-31 → 2025-12-31

EPS$2.57

2020-12-31 → 2025-12-31

Flusso di cassa libero$-51M

2016-12-31 → 2025-12-31

Margine netto-269.4%

2023-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	ATRA	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)	-5.5media 5 anni ≈-27.9	≈-27.9	·	·
P/S (TTM)	14.5media 5 anni ≈71.2	≈71.2	70.6	Sottovalutato
P/B (MRQ)	-2.4media 5 anni ≈34.7	≈34.7	·	·
Price / FCF (Prezzo / FCF)	-1.4media 5 anni ≈-39.1	≈-39.1	·	·
Price / Cash Flow (Prezzo / Flusso di cassa)	-1.4media 5 anni ≈-40.7	≈-40.7	·	·
Price / Tangible Book (Prezzo / Valore contabile tangibile)	7.2media 5 anni ≈68.3	≈68.3	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	ATRA	media 5 anni	Mediana dei peer	Verdetto
Margine Operativo (TTM)	-229.7%media 5 anni ≈-1084.8%	≈-1084.8%	-2434.3%	Di prim'ordine
EBITDA Margin (Margine EBITDA)	29.7%media 5 anni ≈-1084.8%	≈-1084.8%	-2434.3%	Di prim'ordine
Margine ante imposte (TTM)	-269.0%media 5 anni ≈-1086.6%	≈-1086.6%	-3416.0%	Di prim'ordine
Margine di Profitto Netto (TTM)	-269.4%media 5 anni ≈-1086.7%	≈-1086.7%	-2336.0%	Di prim'ordine
ROA (TTM)	-57.6%media 5 anni ≈-46.4%	≈-46.4%	-30.1%	Di prim'ordine
ROE (TTM)	46.3%media 5 anni ≈21.8%	≈21.8%	-50.0%	Debole
ROIC	-93.0%media 5 anni ≈-14.5%	≈-14.5%	-52.7%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	ATRA	media 5 anni	Mediana dei peer	Verdetto
Rapporto corrente (MRQ)	2.0media 5 anni ≈1.9	≈1.9	5.3	Bassa liquidità
Quick Ratio (MRQ)	1.5media 5 anni ≈1.7	≈1.7	3.8	Bassa liquidità
Interest Coverage (Copertura degli interessi)	9.5media 5 anni ≈-20.3	≈-20.3	·	·

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	Tendenza 5 anni	ATRA	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)		-6.3%media 5 anni ≈437.1%	≈437.1%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)		23.8%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	ATRA	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$2.57media 5 anni ≈$-15.98	≈$-15.98	·	·
Revenue / Share (Ricavi / Azione)	$9.50media 5 anni ≈$8.93	≈$8.93	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-4.01media 5 anni ≈$-4.41	≈$-4.41	·	·
Cash / Share (Liquidità / Azione)	$1.16media 5 anni ≈$1.56	≈$1.56	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	ATRA	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)	1.9media 5 anni ≈0.9	≈0.9	0.0	Di prim'ordine
Receivables Turnover (Rotazione dei crediti)	88.3media 5 anni ≈31.9	≈31.9	·	·
Revenue / Employee (Ricavi / Dipendente)	≈$12.1M	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 76.0%

Prossimo report Nov 10, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 10, 2026	$-0.32	$-0.32	0.40%
31 Marzo 2026	Mag 13, 2026	$-0.29	$-0.41	29.8%
31 Dicembre 2025		$-0.25	$-0.17	-43.0%
30 Settembre 2025		$-0.32	$-0.88	63.5%
30 Giugno 2025		$0.19	$-0.47	140.5%
31 Marzo 2025		$3.50	$-2.02	273.3%
31 Dicembre 2024		$-1.19	$-3.65	67.4%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 16

Metrica	2025	2024	2023	2022
Revenue	$121M	$129M	$9M	$64M
R&D Expense	$37M	$151M	$225M	$273M
SG&A Expense	$26M	$40M	$51M	$72M
Operating Expenses	$85M	$212M	$285M	$344M
Operating Income	$36M	$-83M	$-276M	$-281M
Interest Expense	$4M	$5M	$5M	$373.0K
Interest Income	$683.0K	$2M	$5M	$3M
Other Non-op	$-34.0K	$528.0K	$-246.0K	$-700.0K
Pretax Income	$33M	$-85M	$-276M	$-228M
Income Tax	$31.0K	$-12.0K	$15.0K	$12.0K
Net Income	$33M	$-85M	$-276M	$-228M
EPS (Basic)	$2.61	$-11.41	$-65.19	$-2.24
EPS (Diluted)	$2.57	$-11.41	$-65.19	$-2.24
Shares (Basic)	12,544,000	7,488,000	4,236,000	101,990,000
Shares (Diluted)	12,718,000	7,488,000	4,236,000	101,990,000
EBITDA	$36M	$-83M	$-276M	$-281M

Stato Patrimoniale 23

Metrica	2025	2024	2023	2022
Cash & Equivalents	$8M	$25M	$26M	$93M
Short-term Investments	$0	$17M	$26M	$150M
Receivables	$1M	$1M	$34M	$40M
Inventory	$0	$11M	$10M	$2M
Other Current Assets	$2M	$10M	$6M	$10M
Current Assets	$12M	$65M	$102M	$295M
PP&E (Net)	$73.0K	$1M	$4M	$6M
PP&E (Gross)	$286.0K	$19M	$20M	$19M
Accum. Depreciation	$213.0K	$17M	$16M	$12M
Other Non-current Assets	$886.0K	$3M	$5M	$7M
Total Assets	$20M	$109M	$166M	$376M
Accounts Payable	$127.0K	$4M	$4M	$7M
Accrued Liabilities	$2M	$6M	$19M	$7M
Current Liabilities	$15M	$135M	$142M	$79M
Capital Leases	$9M	$30M	$46M	$58M
Other Non-current Liabilities	$2M	$3M	$5M	$6M
Total Liabilities	$59M	$206M	$265M	$250M
Common Stock	$1.0K	$1.0K	$0	$10.0K
Retained Earnings	$-2.02B	$-2.05B	$-1.97B	$-1.69B
AOCI	$1.0K	$8.0K	$-204.0K	$-2M
Stockholders' Equity	$-39M	$-97M	$99M	$127M
Liabilities + Equity	$20M	$109M	$166M	$376M
Shares Outstanding	7,324,000	5,859,000	4,258,000	95,927,000

Flusso di cassa 13

Metrica	2025	2024	2023	2022
D&A	$2M	$5M	$5M	$6M
Stock-based Comp	$10M	$27M	$45M	$54M
Deferred Tax	$0	$0	·	·
Restructuring	$13M	$5M	$7M	$6M
Operating Cash Flow	$-51M	$-69M	$-193M	$-270M
CapEx	$0	$246.0K	$1M	$4M
Investing Cash Flow	$18M	$9M	$124M	$203M
Stock Issued	$1M	$9M	$2M	$22M
Net Stock Activity	$1M	$9M	$2M	$22M
Financing Cash Flow	$16M	$59M	$2M	$53M
Taxes Paid	$190.0K	$24.0K	$2.0K	$19.0K
Free Cash Flow	$-51M	$-69M	$-194M	$-275M
Levered FCF	$-55M	$-74M	$-199M	·

Redditività 7

Metrica	2025	2024	2023	2022
Operating Margin	29.7%	-64.7%	-3219.5%	·
Net Margin	27.1%	-66.2%	-3220.9%	·
Pretax Margin	27.1%	-66.2%	-3220.7%	·
EBITDA Margin	29.7%	-64.7%	-3219.5%	·
ROA	50.5%	-62.2%	-101.9%	-54.1%
ROE	-88.9%	90.9%	368.0%	-145.5%
ROIC	-93.0%	85.8%	278.2%	-221.5%

Liquidità e Solvibilità 3

Metrica	2025	2024	2023	2022
Current Ratio	0.8	0.5	0.7	3.7
Quick Ratio	0.7	0.3	0.6	3.6
Interest Coverage	9.5	-18.1	-52.2	·

Efficienza 2

Metrica	Tendenza	2025	2024	2023	2022
Asset Turnover		1.9	0.9	0.0	·
Receivables Turnover		88.3	7.2	0.2	·

Per Azione 5

Metrica	2025	2024	2023	2022
Book Value / Share	$-5.26	$-16.60	$-0.93	$1.32
Revenue / Share	$9.50	$17.22	$0.08	·
Cash Flow / Share	$-4.01	$-9.18	$-1.82	$-2.65
Cash / Share	$1.16	$4.27	$0.24	$0.97
EPS (TTM)	$2.57	$-11.41	$-65.19	$-2.24

Tassi di Crescita 2

Metrica	Tendenza	2025	2024	2023	2022
Revenue YoY		-6.3%	1404.0%	-86.5%	·
Revenue CAGR 3Y		23.8%	·	·	·

Valutazione (TTM) 10

Metrica	2025	2024	2023	2022
Revenue TTM	$121M	$129M	$9M	$64M
Net Income TTM	$33M	$-85M	$-276M	$-228M
Market Cap	$132M	$78M	$1.37B	$7.87B
P/E	7.0	-1.2	-0.2	-36.6
P/S	1.1	0.6	159.2	123.7
P/B	-3.4	-0.8	-13.8	62.1
P / Tangible Book	·	·	13.8	62.1
P / Cash Flow	-2.6	-1.1	-7.1	-29.1
P / FCF	-2.6	-1.1	-7.0	-28.6
Earnings Yield	14.2%	-85.7%	-508.3%	-2.7%

Conto Economico 16

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$630.0K	$516.0K	$2M	$3M	$18M	$98M	$33M	$40M	$29M	$27M	$4M	$2M	$957.0K	$1M	$221.0K	$4M
R&D Expense	$1M	$164.0K	$-223.0K	$3M	$7M	$27M	$29M	$44M	$33M	$46M	$50M	$57M	$56M	$62M	$63M	$70M
SG&A Expense	$4M	$4M	$4M	$4M	$7M	$11M	$9M	$10M	$9M	$11M	$11M	$12M	$13M	$14M	$13M	$19M
Operating Expenses	$5M	$4M	$4M	$7M	$14M	$59M	$45M	$62M	$47M	$59M	$64M	$72M	$72M	$76M	$76M	$89M
Operating Income	$-5M	$-3M	$-3M	$-4M	$3M	$39M	$-12M	$-22M	$-18M	$-31M	$-60M	$-70M	$-71M	$-75M	$-76M	$-85M
Interest Expense	$191.0K	$830.0K	$894.0K	$909.0K	$972.0K	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$117.0K	$123.0K
Interest Income	$78.0K	$54.0K	$100.0K	$204.0K	$143.0K	$236.0K	$597.0K	$459.0K	$450.0K	$604.0K	$711.0K	$1M	$2M	$2M	$1M	$973.0K
Other Non-op	$0	$0	$-49.0K	$4.0K	$22.0K	$-11.0K	$-89.0K	$555.0K	$-6.0K	$68.0K	$-12.0K	$-27.0K	$-10.0K	$-197.0K	$-68.0K	$-309.0K
Pretax Income	$-5M	$-4M	$-3M	$-4M	$2M	$38M	$-13M	$-22M	$-19M	$-32M	$-60M	$-70M	$-71M	$-75M	$-75M	$-84M
Income Tax	$1.0K	$0	$0	$28.0K	$3.0K	$0	$-19.0K	$-17.0K	$0	$24.0K	$11.0K	$-19.0K	$1.0K	$22.0K	$2.0K	$10.0K
Net Income	$-5M	$-4M	$-3M	$-4M	$2M	$38M	$-13M	$-22M	$-19M	$-32M	$-60M	$-70M	$-71M	$-75M	$-75M	$-84M
EPS (Basic)	$-0.32	$-0.29	$-0.80	$-0.32	$0.20	$3.53	$0.27	$-2.93	$-3.10	$-5.65	$-31.16	$-16.40	$-16.91	$-0.72	$-0.73	$-0.82
EPS (Diluted)	$-0.32	$-0.29	$-0.80	$-0.32	$0.19	$3.50	$0.27	$-2.93	$-3.10	$-5.65	$-31.16	$-16.40	$-16.91	$-0.72	$-0.73	$-0.82
Shares (Basic)	15,033,000	14,081,000	·	13,564,000	12,197,000	10,764,000	·	7,466,000	6,143,000	5,623,000	·	4,256,000	4,204,000	103,969,000	·	102,423,000
Shares (Diluted)	15,033,000	14,081,000	·	13,564,000	12,310,000	10,851,000	·	7,466,000	6,143,000	5,623,000	·	4,256,000	4,204,000	103,969,000	·	102,423,000
EBITDA	·	$-3M	·	$-4M	$3M	$39M	·	$-22M	$-18M	$-31M	·	$-70M	$-71M	$-75M	·	$-85M

Stato Patrimoniale 24

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$3M	$8M	$8M	$6M	$17M	$14M	$25M	$46M	$31M	$35M	$26M	$65M	$46M	$49M	$93M	$65M
Short-term Investments	$7M	·	$0	$8M	$5M	$0	$17M	$21M	$4M	$11M	$26M	$38M	$108M	$157M	$150M	$200M
Receivables	$318.0K	$0	$1M	$2M	$0	$9M	$1M	$1M	$2M	$36M	$34M	$163.0K	$507.0K	$397.0K	$40M	$249.0K
Inventory	·	·	$0	$0	$0	$0	$11M	$14M	$19M	$16M	$10M	$7M	$8M	$5M	$2M	·
Prepaid Expense	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$16M
Other Current Assets	$3M	$4M	$2M	$3M	$2M	$4M	$10M	$9M	$6M	$8M	$6M	$9M	$10M	$13M	$10M	·
Current Assets	$14M	$12M	$12M	$18M	$25M	$27M	$65M	$92M	$62M	$106M	$102M	$119M	$172M	$224M	$295M	$283M
PP&E (Net)	$41.0K	$55.0K	$73.0K	$147.0K	$176.0K	$285.0K	$1M	$2M	$2M	$3M	$4M	$5M	$5M	$6M	$6M	$7M
PP&E (Gross)	·	·	$286.0K	$551.0K	$551.0K	$2M	$19M	$20M	$20M	$20M	$20M	$20M	$20M	$19M	$19M	$20M
Accum. Depreciation	·	·	$213.0K	$404.0K	$375.0K	$2M	$17M	$18M	$17M	$17M	$16M	$15M	$14M	$13M	$12M	$12M
Other Non-current Assets	$765.0K	$890.0K	$886.0K	$881.0K	$927.0K	$3M	$3M	$3M	$4M	$4M	$5M	$6M	$7M	$7M	$7M	$7M
Total Assets	$21M	$20M	$20M	$30M	$37M	$62M	$109M	$143M	$117M	$165M	$166M	$189M	$246M	$302M	$376M	$368M
Accounts Payable	$824.0K	$637.0K	$127.0K	$318.0K	$2M	$1M	$4M	$2M	$5M	$3M	$4M	$7M	$4M	$5M	$7M	$11M
Accrued Liabilities	$2M	$2M	$2M	$3M	$5M	$9M	$6M	$8M	$11M	$18M	$19M	$8M	$11M	$7M	$7M	·
Current Liabilities	$7M	$6M	$15M	$18M	$15M	$48M	$135M	$156M	$148M	$181M	$142M	$79M	$75M	$68M	$79M	$72M
Capital Leases	$9M	$9M	$9M	$15M	$15M	$27M	$30M	$35M	$39M	$42M	$46M	$49M	$52M	$55M	$58M	$61M
Other Non-current Liabilities	$2M	$2M	$2M	$2M	$2M	$3M	$3M	$4M	$4M	$4M	$5M	$5M	$5M	$5M	$6M	$6M
Total Liabilities	$58M	$57M	$59M	$67M	$72M	$117M	$206M	$233M	$228M	$264M	$265M	$240M	$239M	$237M	$250M	$181M
Common Stock	$1.0K	$1.0K	$1.0K	$1.0K	$1.0K	$1.0K	$1.0K	$1.0K	$0	$12.0K	$0	$10.0K	$10.0K	$10.0K	$10.0K	$9.0K
Retained Earnings	$-2.03B	$-2.03B	$-2.02B	$-2.02B	$-2.01B	$-2.02B	$-2.05B	$-2.04B	$-2.02B	$-2.00B	$-1.97B	$-1.91B	$-1.84B	$-1.77B	$-1.69B	$-1.62B
AOCI	$-2.0K	$0	$1.0K	$2.0K	$0	$0	$8.0K	$22.0K	$-14.0K	$-55.0K	$-204.0K	$-571.0K	$-933.0K	$-1M	$-2M	$-3M
Stockholders' Equity	$-37M	$-37M	$-39M	$-37M	$-35M	$-55M	$-97M	$-91M	$-111M	$-98M	$-99M	$-51M	$7M	$65M	$127M	$187M
Liabilities + Equity	$21M	$20M	$20M	$30M	$37M	$62M	$109M	$143M	$117M	$165M	$166M	$189M	$246M	$302M	$376M	$368M
Shares Outstanding	9,443,000	8,512,000	7,324,000	7,210,000	6,978,000	5,924,000	5,859,000	5,740,000	4,904,000	120,325,000	4,258,000	101,922,000	101,102,000	96,538,000	95,927,000	94,879,000

Flusso di cassa 12

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$14.0K	$29.0K	$49.0K	$36.0K	$236.0K	$2M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M
Stock-based Comp	$394.0K	$749.0K	$2M	$1M	$3M	$4M	$6M	$6M	$6M	$8M	$10M	$11M	$13M	$12M	$11M	$14M
Restructuring	$767.0K	$0	$1M	$27.0K	$2M	$10M	$0	$0	$356.0K	$5M	$7M	$0	$0	$45.0K	$74.0K	$6M
Operating Cash Flow	$-3M	$-3M	$-6M	$-10M	$-7M	$-28M	$-24M	$-4M	$-11M	$-30M	$-50M	$-51M	$-53M	$-38M	$-57M	$-65M
CapEx	·	·	$0	$0	$0	$0	$90.0K	$0	$29.0K	$127.0K	$44.0K	$281.0K	$499.0K	$399.0K	$37.0K	$132.0K
Investing Cash Flow	$-7M	$0	$8M	$-2M	$-5M	$17M	$3M	$-17M	$7M	$15M	$10M	$70M	$49M	$-6M	$51M	$60M
Stock Issued	$5M	$3M	$-25.0K	$1M	$0	$0	$0	$0	$-26.0K	$9M	$2M	$0	$-50.0K	$640.0K	$1M	$0
Net Stock Activity	·	$3M	·	·	·	$0	·	·	·	$9M	·	·	·	$640.0K	·	·
Financing Cash Flow	$5M	$3M	$-3.0K	$1M	$15M	$-250.0K	$-328.0K	$36M	$-324.0K	$24M	$2M	$-208.0K	$471.0K	$235.0K	$32M	$-214.0K
Taxes Paid	·	·	$159.0K	$28.0K	$3.0K	$0	$0	$0	$0	$24.0K	$0	$0	$1.0K	$1.0K	$0	$0
Free Cash Flow	·	·	·	·	·	$-28M	·	·	·	$-30M	·	·	·	$-39M	·	·
Levered FCF	·	·	·	·	·	$-29M	·	·	·	$-31M	·	·	·	$-40M	·	·

Redditività 7

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	·	-652.9%	·	-103.5%	18.2%	39.5%	·	-54.1%	-63.7%	-114.2%	·	-3255.9%	-7462.3%	-6118.9%	·	·
Net Margin	·	-803.3%	·	-124.6%	13.6%	38.7%	·	-54.5%	-66.5%	-116.1%	·	-3264.6%	-7430.3%	-6098.8%	·	·
Pretax Margin	·	-803.3%	·	-123.8%	13.6%	38.7%	·	-54.6%	-66.5%	-116.0%	·	-3265.5%	-7430.2%	-6097.0%	·	·
EBITDA Margin	·	-652.9%	·	-103.5%	18.2%	39.5%	·	-54.1%	-63.7%	-114.2%	·	-3255.9%	-7462.3%	-6118.9%	·	·
ROA	·	-10.1%	·	-5.0%	3.1%	33.4%	·	-13.2%	-10.5%	-13.6%	·	-25.1%	-20.8%	-21.4%	·	-20.5%
ROE	·	9.0%	·	6.8%	-3.3%	-49.6%	·	31.0%	36.8%	190.4%	·	-102.4%	-53.7%	-51.7%	·	-33.8%
ROIC	·	9.0%	·	9.8%	-9.1%	-70.5%	·	24.0%	16.4%	31.8%	·	136.9%	-958.1%	-115.5%	·	-45.2%

Liquidità e Solvibilità 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	·	2.2	·	1.0	1.7	0.6	·	0.6	0.4	0.6	·	1.5	2.3	3.3	·	3.9
Quick Ratio	·	1.5	·	0.9	1.5	0.5	·	0.4	0.3	0.5	·	1.3	2.1	3.0	·	3.7
Interest Coverage	·	-4.1	·	-3.9	3.3	38.2	·	-18.4	-14.4	-27.1	·	-49.9	-51.8	-56.2	·	·

Efficienza 2

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		·	0.0	·	0.0	0.2	0.9	·	0.2	0.2	0.1	·	0.0	0.0	0.0	·	·
Receivables Turnover		·	0.1	·	2.1	14.5	4.4	·	53.7	19.6	1.5	·	10.4	1.7	2.3	·	·

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	·	$-4.38	·	$-5.08	$-5.02	$-9.30	·	$-15.77	$-22.61	$-0.82	·	$-0.50	$0.07	$0.67	·	$1.97
Revenue / Share	·	$0.04	·	$0.25	$1.43	$9.05	·	$5.38	$4.66	$0.19	·	$0.02	$0.01	$0.01	·	·
Cash Flow / Share	·	$-0.22	·	·	·	$-2.59	·	·	·	$-0.21	·	·	·	$-0.37	·	·
Cash / Share	·	$0.98	·	$0.80	$2.42	$2.34	·	$8.09	$6.39	$0.29	·	$0.64	$0.45	$0.50	·	$0.69
EPS (TTM)	$-0.74	$-1.22	·	$3.64	$1.03	$-2.26	·	$-42.84	$-56.31	$-70.12	·	$-34.76	$-19.18	$-2.09	·	$-2.47

Valutazione (TTM) 9

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$22M	$23M	·	$152M	$189M	$200M	·	$100M	$62M	$35M	·	$5M	$7M	$57M	·	·
Net Income TTM	$-11M	$-9M	·	$23M	$6M	$-16M	·	$-133M	$-181M	$-233M	·	$-290M	$-305M	$-215M	·	$-247M
Market Cap	·	$40M	·	$103M	$54M	$35M	·	$47M	$42M	$2.09B	·	$3.77B	$4.07B	$7.00B	·	$8.97B
P/E	-15.5	-3.9	·	3.9	7.5	-2.6	·	-0.2	-0.2	-0.2	·	-1.1	-2.1	-34.7	·	-38.3
P/S	·	1.7	·	0.7	0.3	0.2	·	0.5	0.7	60.2	·	830.3	592.9	121.8	·	·
P/B	·	-1.1	·	-2.8	-1.5	-0.6	·	-0.5	-0.4	-21.2	·	-74.2	545.9	107.7	·	47.9
P / Tangible Book	·	·	·	·	·	·	·	·	·	·	·	·	545.9	107.7	·	47.9
P / Cash Flow	·	-13.1	·	·	·	-1.3	·	·	·	-70.5	·	·	·	-182.1	·	·
Earnings Yield	-6.5%	-25.8%	·	25.4%	13.3%	-38.0%	·	-526.9%	-662.5%	-404.2%	·	-94.0%	-47.6%	-2.9%	·	-2.6%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$121M	$129M	$9M	$64M	·
Margine Operativo %	29.7%	-64.7%	-3219.5%	·	·
Utile netto	$33M	$-85M	$-276M	$-228M	$-340M
EPS Diluito	$2.57	$-11.41	$-65.19	$-2.24	$-3.63

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	0.8	0.5	0.7	3.7	3.6
Quick Ratio	0.7	0.3	0.6	3.6	3.5

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-51M	$-69M	$-194M	$-275M	$-231M

Proprietari istituzionali (13F) 38 filer · $54.9M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 38

Valore detenuto $54.9M

Nuove posizioni 4

Posizioni chiuse 1

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
4 (-3 vs trimestre precedente)	1 (-13 vs trimestre precedente)	12 (+2 vs trimestre precedente)	8 (+5 vs trimestre precedente)	+1.9M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
EcoR1 Capital, LLC	$17.816.960	1.552.000	32,43%	Azioni
ADAGE CAPITAL PARTNERS GP, L.L.C.	$9.758.000	850.000	17,76%	Azioni
Point72 Asset Management, L.P.	$7.895.003	687.718	14,37%	Azioni
Redmile Group, LLC	$5.070.727	441.701	9,23%	Azioni
VANGUARD GROUP INC	$4.087.255	225.940	7,44%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$2.836.100	247.047	5,16%	Azioni
MACKENZIE FINANCIAL CORP	$2.677.699	233.249	4,87%	Azioni
BlackRock, Inc.	$969.544	84.455	1,76%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$862.924	75.128	1,57%	Azioni
STALEY CAPITAL ADVISERS INC	$574.000	50.000	1,04%	Azioni
VANGUARD FIDUCIARY TRUST CO	$494.053	43.036	0,90%	Azioni
JANE STREET GROUP, LLC	$348.360	30.345	0,63%	Azioni
STATE STREET CORP	$303.680	26.453	0,55%	Azioni
NORTHERN TRUST CORP	$190.465	16.591	0,35%	Azioni
FMR LLC	$186.412	16.238	0,34%	Azioni
XTX Topco Ltd	$175.678	15.303	0,32%	Azioni
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$160.720	14.000	0,29%	Azioni
MILLENNIUM MANAGEMENT LLC	$145.566	12.680	0,26%	Azioni
CITADEL ADVISORS LLC	$116.625	10.159	0,21%	Azioni
MORGAN STANLEY	$105.368	9.178	0,19%	Azioni
ROYAL BANK OF CANADA	$55.000	4.743	0,10%	Azioni
UBS Group AG	$45.679	3.979	0,08%	Azioni
Vanguard Global Advisers, LLC	$16.715	1.456	0,03%	Azioni
SBI Securities Co., Ltd.	$16.118	1.404	0,03%	Azioni
JONES FINANCIAL COMPANIES LLLP	$8.440	803	0,02%	Azioni
Caitong International Asset Management Co., Ltd	$3.570	311	0,01%	Azioni
BARCLAYS PLC	$3.490	304	0,01%	Azioni
Banque Transatlantique SA	$3.096	176	0,01%	Azioni
WELLS FARGO & COMPANY/MN	$2.881	251	0,01%	Azioni
JPMORGAN CHASE & CO	$2.413	216	0,00%	Azioni
Raiffeisen Bank International AG	$2.296	200	0,00%	Opzione Call
CITIGROUP INC	$1.114	97	0,00%	Azioni
BNP PARIBAS FINANCIAL MARKETS	$528	46	0,00%	Azioni
ACADIAN ASSET MANAGEMENT LLC	$444	38.845	0,00%	Azioni
PlanVest Financial, Inc	$321	28	0,00%	Azioni
KERR FINANCIAL PLANNING Corp	$276	24	0,00%	Azioni
OSAIC HOLDINGS, INC.	$114	10	0,00%	Azioni
Rockefeller Capital Management L.P.	$92	8	0,00%	Azioni

Attivisti e proprietari del 5%+ 3 partecipazioni

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
Redmile Group, LLC, Green Jeremy, Redmile Biopharma Investments II, L.P., Redmile Strategic Long Only Trading Sub, Ltd. ×4 depositi	24 Luglio 2026	9,90%	Modifica	·	SEC
Panacea Innovation Limited, Panacea Venture Healthcare Fund II, L.P., Panacea Venture Healthcare Fund II GP Company, Ltd., Panacea Opportunity Fund I, L.P., Panacea Opportunity Fund I GP Company, Ltd., James Huang ×4 depositi	11 Maggio 2026	16,10%	Modifica	·	SEC
Adiumentum Capital Fund I LP, Adiumentum Capital Fund I GP LLC, Gregory A. Ciongoli ×3 depositi	16 Maggio 2025	19,99%	Modifica	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 35 insider · 19 dirigenti · 16 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Acquisti 12m	Vendite 12m	Netto 12m
Anhco Nguyen	President and CEO	17 Agosto 2026 S	132.775	0	8	$-142.448
Isaac E. Ciechanover	Chief Executive Officer	30 Maggio 2019 S	290.687	0	0	$0
Utpal Koppikar	Chief Financial Officer	02 Marzo 2023 S	181.978	0	0	$0
John Mcgrath	EVP & Chief Financial Officer	20 Marzo 2018 S	88.762	0	0	$0
Yanina Grant-Huerta	Chief Accounting Officer	18 Maggio 2026 S	49.636	0	8	$-56.523
Jill Henrich	EVP, Chief Regulatory Officer	03 Marzo 2025 S	18.679	0	0	$0
Amar Murugan	EVP, Chief Legal Officer	16 Agosto 2024 S	26.827	0	0	$0
Manher Joshi	EVP, Chief Medical Officer	16 Novembre 2023 S	171.284	0	0	$0
Charlene A. Banard	EVP, Chief Technical Officer	16 Maggio 2023 S	276.010	0	0	$0
Jakob Dupont	EVP, Head of R&D	02 Marzo 2023 S	290.794	0	0	$0
Kristin Yarema	Chief Commercial Officer	01 Marzo 2022 A	171.415	0	0	$0
Joe Newell	Chief Operations Officer	16 Novembre 2021 S	113.097	0	0	$0
Dietmar Berger	Global Head of R&D	07 Maggio 2019 F	85.678	0	0	$0
Mina Kim	Senior VP & General Counsel	09 Aprile 2019 F	66.389	0	0	$0
Derrell Porter	SVP, Head of Global Commercial	26 Marzo 2019 A	31.688	0	0	$0
Christopher Haqq	EVP, R&D & Chief Scientific Of	15 Febbraio 2019 S	271.943	0	0	$0
Gad Soffer	EVP & Chief Strategy Officer	22 Settembre 2018 F	243.966	0	0	$0
Mitchall G. Clark	EVP & Chief R & QA Officer	18 Maggio 2018 S	107.972	0	0	$0
Heather D Turner	Former EVP, GC & Sec.	09 Febbraio 2018 S	69.494	0	0	$0
Brian N Cherry	Direttore	04 Settembre 2026 P	166.486	1	0	$999.994
Gregory A. Ciongoli	Direttore	09 Giugno 2026 A	12.000	0	0	$0
Matthew K Fust	Direttore	09 Giugno 2026 A	30.188	0	0	$0
William K Heiden	Direttore	09 Giugno 2026 A	34.188	0	0	$0
Ameet Mallik	Direttore	10 Giugno 2025 A	16.928	0	0	$0
Maria Grazia Roncarolo	Direttore	10 Giugno 2025 A	17.368	0	0	$0
Pascal Touchon	Direttore	10 Giugno 2025 A	77.955	0	0	$0
Carol Giltner Gallagher	Direttore	10 Giugno 2025 A	33.012	0	0	$0
Eric Dobmeier	Direttore	10 Novembre 2023 P	563.325	0	0	$0
Beth C Seidenberg	Direttore	31 Maggio 2023 A	115.689	0	0	$0
Roy D. Baynes	Direttore	23 Giugno 2022 A	43.500	0	0	$0
Ronald C Renaud JR	Direttore	23 Giugno 2022 A	31.500	0	0	$0
Joel S Marcus	Direttore	15 Marzo 2019 S	888.355	0	0	$0
Eckard Weber	Direttore	16 Gennaio 2015 A	·	0	0	$0
EcoR1 Capital, LLC	Proprietario del 10%	07 Maggio 2026 P	1.552.000	1	0	$4.744.255
Eric J Hyllengren	·	31 Marzo 2025 D	56.231	0	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 4 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
IWC · iShares Trust	0,01%	18.824 SH	11 Settembre 2026	Giornaliero
VXF · VANGUARD INDEX FUNDS	0,00%	82.758 SH	19 Agosto 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	158.646 SH	19 Agosto 2026	Giornaliero
DFAS · Dimensional ETF Trust	0,00%	135 NS	31 Luglio 2026	N-PORT

ATRA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 10 analisti COMPRA

Target mediano $13.00 +37,1%

2 20,0% Acquisto forte

6 60,0% Compra

2 20,0% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

3 analisti · 2026-10-02

Target medio $13.67 +44,2%

← Sotto tutti i target Prezzo attuale $9.48

Basso$10.00 Media$13.67 Alto$18.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
ATRA	$132M	7.0	-6.3%	27.1%	-88.9%	·
CNXU	·	·	·	·	·	·
RLYB	$4M	-0.4	34.9%	-1046.4%	-17.3%	·
MNOV	$64M	-5.5	·	-2928.8%	-27.1%	·
ICCC	·	-51.2	4.3%	·	·	·
ACRV	$76M	-1.2	·	·	-61.0%	·
SERA	·	-4.4	5.2%	-39417.3%	-39.0%	·
GRML	·	·	·	·	-104.9%	·
GANX	$135M	-5.3	-60.6%	·	-181.1%	·

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

ATRA Atara Biotherapeutics, Inc. - Common Stock